Synchronisation and control of proliferation in cycling cell population models with age structure

Mathematics and Computers in Simulation

Volumn 96, Issue , 2014, Pages 66-94

  Billy, Frédérique ^a,b   Clairambaultt, Jean ^a,b   Fercoq, Olivier ^c,d   Gaubertt, Stéphane ^c,d   Lepoutre, Thomas ^e,f,g   Ouillon, Thomas ^h   Saito, Shoko ^i,j  

^a INRIA   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INRIA SACLAY   (France)

^d CENTRE DE MATHÉMATIQUES APPLIQUÉES   (France)

^e INRIA RHÔNE ALPES   (France)

^f UNIVERSITÉ DE LYON   (France)

^g UNIVERSITÉ LYON 1   (France)

^h ENSTA PARISTECH   (France)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

^j UNIVERSITY OF TSUKUBA   (Japan)

more..

Author keywords

Age structured models; Cell division cycle; Cell population dynamics; Drug delivery optimisation; Mathematical models

Indexed keywords

AGE STRUCTURED MODEL; ANTI-CANCER THERAPEUTICS; CELL DIVISION CYCLE; CELL POPULATION DYNAMICS; DIFFERENTIAL OPERATORS; OPTIMISATIONS; PROLIFERATING CELL POPULATION; THEORETICAL TREATMENTS;

ALGORITHMS; CELL CULTURE; CELLS; DISEASES; DRUG DELIVERY; EIGENVALUES AND EIGENFUNCTIONS; MAMMALS; MATHEMATICAL MODELS; MATHEMATICAL OPERATORS; OPTIMIZATION; TUMORS;

CELL PROLIFERATION;

EID: 84888313883     PISSN: 03784754     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matcom.2012.03.005     Document Type: Article

References (92)

1. A. Altinok, D. Gonze, F. Lévi, and A. Goldbeter An automaton model for the cell cycle Interface Focus 1 2011 36 47
2. A. Altinok, F. Lévi, and A. Goldbeter A cell cycle automaton model for probing circadian patterns of anticancer drug delivery Advanced Drug Delivery Reviews 59 2007 1036-1010
3. A. Altinok, F. Lévi, and A. Goldbeter Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling European Journal of Pharmaceutical Sciences 36 2009 20 38
4. O. Arino A survey of structured cell population dynamics Acta Biotheoretica 43 1995 3 25
5. O. Arino, and M. Kimmel Comparison of approaches to modeling of cell population dynamics SIAM Journal on Applied Mathematics 53 1993 1480 1504
6. O. Arino, and E. Sanchez A survey of cell population dynamics Journal of Theoretical Medicine 1 1997 35 51
7. O. Arino, and E. Sanchez A survey of cell population dynamics Journal of Theoretical Medicine 1 1997 35 51 (Pubitemid 38159640)
8. N. Baghdassarian, R. Catallo, M.A. Mahly, P. Ffrench, F. Chizat, P.A. Bryon, and M. Ffrench Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins Experimental Cell Research 240 1998 263 273 (Pubitemid 28371107)
9. C. Basdevant, J. Clairambault, and F. Lévi Optimisation of time-scheduled regimen for anti-cancer drug infusion Mathematical Modelling and Numerical Analysis 39 2006 1069 1086 (Pubitemid 43057978)
10. F. Bekkal Brikci, J. Clairambault, and B. Perthame Analysis of a molecular structured population model with polynomial growth for the cell cycle Mathematical and Computer Modelling 47 2008 699 713 (Pubitemid 351335335)
11. F. Bekkal Brikci, J. Clairambault, B. Ribba, and B. Perthame An age-and-cyclin-structured cell population model for healthy and tumoral tissues Journal of Mathematical Biology 57 2008 91 110
12. A. Berman, and R.J. Plemmons Nonnegative matrices in the mathematical sciences American Mathematical Society 1994
13. S. Bernard, B. ̌Cajavec Bernard, F. Lévi, and H. Herzel Tumor growth rate determines the timing of optimal chronomodulated treatment schedules PLoS Computational Biology 6 3 2010 e1000712
14. S. Bernard, L. Pujo-Menjouet, and M.C. Mackey Analysis of cell kinetics using a cell division marker: mathematical modeling of experimental data Biophysical Journal 84 2003 3414 3424 (Pubitemid 36531786)
15. D.P. Bertsekas On the Goldstein - Levitin - Polyak gradient projection method IEEE Transactions on Automatic Control AC-21 1976 174 184
16. D.P. Bertsekas, Constrained Optimization and Lagrange multiplier method, Academic Press, NY; republished by Athena Scientific, MA, 1997, 1982.
17. D.P. Bertsekas Nonlinear Programming 1995 Athena Scientific
18. F. Billy, J. Clairambault, O. Fercoq, Optimisation of cancer drug treatments using cell population dynamics, in: U. Ledzewicz, H. Schättler, A. Friedman, E. Kashdan (Eds.), Mathematical Methods and Models in Biomedicine, Springer, 2012, pp. 263-299.
19. G.A. Bjarnason, R.C.K. Jordan, and R.B. Sothern Circadian variation in the expression of cell-cycle proteins in the human oral epithelium American Journal of Pathology 154 1999 613 622 (Pubitemid 29094110)
20. G.A. Bjarnason, R.C.K. Jordan, P.A. Wood, Q. Li, D.W. Lincoln, R.B. Sothern, W.J. Hrushesky, and Y. Ben-David Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases American Journal of Pathology 158 2001 1793 1801 (Pubitemid 32422944)
21. G. Bocci, R. Danesi, A.D. Di Paolo, F. Innocenti, G. Allegrini, and A. Falcone Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients Clinical Cancer Research 6 2000 3032 3037 (Pubitemid 30637725)
22. J.F. Bonnans, J.C. Gilbert, C. Lemaréchal, and C. Sagastizábal Numerical Optimization - Theoretical and Practical Aspects, Universitext 2006 Springer Verlag Berlin
23. R.M. Buijs, and A. Kalsbeek Hypothalamic integration of central and peripheral clocks Nature Reviews: Neuroscience 2 2001 521 526 (Pubitemid 33676587)
24. 0 phase in the cell cycle Cell and Tissue Kinetics 3 1970 321 334
25. G. Chiorino, J.A.J. Metz, D. Tomasoni, and P. Ubezio Desynchronization rate in cell populations: mathematical modeling and experimental data Journal of Theoretical Biology 208 2001 185 199 (Pubitemid 32099420)
26. J. Cicenas, and M. Valius The cdk inhibitors in cancer research and therapy Journal of Cancer Research and Clinical Oncology 137 2011 1409 1418
27. J. Clairambault Modelling oxaliplatin drug delivery to circadian rhythm in drug metabolism and host tolerance Advanced Drug Delivery Reviews 59 2007 1054 1068 (Pubitemid 47542289)
28. J. Clairambault A step toward optimization of cancer therapeutics physiologically based modelling of circadian control on cell proliferation IEEE-EMB Magazine 27 2008 20 24
29. J. Clairambault Modelling physiological and pharmacological control on cell proliferation to optimise cancer treatments Mathematical Modelling of Natural Phenomena 4 2009 12 67
30. J. Clairambault Optimising cancer pharmacotherapeutics using mathematical modelling and a systems biology approach Personalized Medicine 8 2011 271 286
31. J. Clairambault, S. Gaubert, and T. Lepoutre Comparison of Perron and Floquet eigenvalues in age structured cell division models Mathematical Modelling of Natural Phenomena 4 2009 183 209
32. J. Clairambault, S. Gaubert, and T. Lepoutre Circadian rhythm and cell population growth Mathematical and Computer Modelling 53 2011 1558 1567
33. J. Clairambault, S. Gaubert, and B. Perthame An inequality for the Perron and Floquet eigenvalues of monotone differential systems and age-structured equations Comptes Rendus De L'Academie Des Sciences Serie I Mathématique 345 2007 549 554
34. J. Clairambault, B. Laroche, S. Mischler, B. Perthame, A mathematical model of the cell cycle and its control, Technical Report, INRIA, Domaine de Voluceau - Rocquencourt - BP 105 - 78153 Le Chesnay Cedex (France), 2003.
35. J. Clairambault, P. Michel, and B. Perthame Circadian rhythm and tumour growth Comptes Rendus De L'Academie Des Sciences Serie I Mathématique (Équations aux dérivées partielles) 342 2006 17 22 (Pubitemid 43055624)
36. J. Clairambault, P. Michel, and B. Perthame A model of the cell cycle and its circadian control A. Deutsch, L. Brusch, H. Byrne, G. de Vries, J. Herzel, Mathematical Modeling of Biological Systems, Volume I: Cellular Biophysics, Regulatory Networks, Development, Biomedicine, and Data Analysis 2007 Birkhäuser Boston 239 251
37. A.A. Cohen, T. Kalisky, A. Mayo, N. Geva-Zatorsky, T. Danon, I. Issaeva, R. Kopito, N. Perzov, R. Milo, A. Sigal, and U. Alon Protein dynamics in individual human cells: experiment and theory PLoS One 4 2009 1 12 E4901
38. R.B. Diasio, and B.E. Harris Clinical pharmacology of 5-fluorouracil Clinical Pharmacokinetics 16 1989 215 237 (Pubitemid 19114713)
39. E. Filipski, P.F. Innominato, M.W. Wu, X.M. Li, S. Iacobelli, L.J. Xian, and F. Lévi Effect of light and food schedules on liver and tumor molecular clocks in mice Journal of the National Cancer Institute 97 2005 507 517 (Pubitemid 40590432)
40. E. Filipski, V.M. King, X.M. Li, T.G. Granda, and F. Lévi Host circadian clock as a control point in tumor progression Journal of the National Cancer Institute 94 2002 690 697 (Pubitemid 34552490)
41. L. Fu, H. Pelicano, J. Liu, P. Huang, and C.C. Lee The circadian gene per2 plays an important role in tumor suppression and DNA damage response in vivo Cell 111 2002 41 50
42. S.P. Garbett, P. Gabriel, D.R. Tyson, G.F. Webb, V. Quaranta. The contribution of age structure to cell population responses to targeted therapeutics, in revision.
43. J.H. Goldie, and A.J. Coldman Drug Resistance in Cancer: Mechanisms and Models 1998 Cambridge University Press
44. A.A. Goldstein Convex programming in hilbert space Bulletin of the American Mathematical Society 70 1964 709 710
45. A.A. Goldstein Constructive Real Analysis 1967 Harper & Row New York
46. G.H. Golub, and C.F. Van Loan Matrix Computations 1989 Johns Hopkins University Press Baltimore, MD
47. A. Gréchez-Cassiau, B. Rayet, F. Guillaumond, M. Teboul, and F. Delaunay The circadian clock component bmal1 is a critical regulator of p21(waf1/cip1) expression and hepatocyte proliferation Journal of Biological Chemistry 283 2008 4535 4542
48. M. Gyllenberg, A. Osipov, and L. Päivärinta The inverse problem of linear age-structured population dynamics Journal of Evolution Equations 2 2002 223 239
49. M.B. Kastan, and J. Bartek Cell-cycle checkpoints and cancer Nature 432 2004 316 323 (Pubitemid 39551659)
50. T. Kato Perturbation Theory for Linear Operators 1966 Springer-Verlag Berlin and Heidelberg GmbH & Co. K
51. M. Kimmel, and A. Świerniak Control theory approach to cancer chemotherapy: benefiting from phase dependence and overcoming drug resistance A. Friedman, Tutorials in Mathematical Biosciences III, Volume 1872 of Lecture Notes in Mathematics 2006 Springer Berlin/Heidelberg 185 221
52. N. Komarova, and D. Wodarz Drug resistance in cancer: principles of emergence and prevention Proceedings of the National Academy of Sciences of the United States of America 102 2005 9714 9719 (Pubitemid 40981746)
53. R.K. Konopka, and S. Benzer Clock mutants of drosophila melanogaster Proceedings of the National Academy of Sciences of the United States of America 68 1971 2112 2116
54. A. Kramer, F. Yang, P. Snodgrass, X. Li, and T.E. Scammell Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling Science 294 2001 2511 2515 (Pubitemid 34027284)
55. T. Lepoutre, Analyse et modélisation de phénomènes de croissance et mouvement issus de la biologie, Ph.D. thesis, Université Paris VI Pierre et Marie Curie, 4, place Jussieu - 75005 Paris (France), 2009. Available online from http://tel.archives-ouvertes.fr/tel-00457561/fr/.
56. F. Lévi Cancer chronotherapeutics Special Issue of Chronobiology International 19 2002 1 19
57. F. Lévi Chronotherapeutics: the relevance of timing in cancer therapy Cancer Causes Control 17 2006 611 621
58. F. Lévi The circadian timing system: a coordinator of life processes. implications for the rhythmic delivery of cancer therapeutics IEEE-EMB Magazine 27 2008 17 20
59. F. Lévi, A. Altinok, J. Clairambault, and A. Goldbeter Implications of circadian clocks for the rhythmic delivery of cancer therapeutics Philosophical Transactions of the Royal Society of London Series A 366 2008 3575 3598
60. F. Lévi, A. Okyar, S. Dulong, P.F. Innominato, and J. Clairambault Circadian timing in cancer treatments Annual Review of Pharmacology and Toxicology 50 2010 377 421
61. F. Lévi, and U. Schibler Circadian rhythms: mechanisms and therapeutic implications Annual Review of Pharmacology and Toxicology 47 2007 493 528
62. A.S. Lewis, and M.L. Overton Eigenvalue optimization Acta Numerica 5 1996 149 190 (Pubitemid 126090738)
63. H. Lodish, A. Berk, C.A. Kaiser, M. Krieger, M.P. Scott, A. Bretscher, H. Ploegh, P.T. Matsudaira, Molecular Cell Biology, 6th ed., W.H. Freeman, New York, 2007.
64. L. Ma, J. Wagner, J.J. Rice, W. Hu, A.J. Levine, and G.A. Stolovitzky A plausible model for the digital response of p53 to DNA damage Proceedings of the National Academy of Sciences 102 2005 14266 14271 (Pubitemid 41429687)
65. T. Matsuo, S. Yamaguchi, S. Mitsuia, A. Emi, F. Shimoda, and H. Okamura Control mechanism of the circadian clock for timing of cell division in vivo Science 302 2003 255 259 (Pubitemid 37248750)
66. H.H. McAdams, and A. Arkin Stochastic mechanisms in gene expression Proceedings of the National Academy of Sciences of the United States of America 31 1997 814 819 (Pubitemid 27074404)
67. A.G. McKendrick Applications of mathematics to medical problems Proceedings of the Edinburgh Mathematical Society 54 1926 98 130
68. J.A.J. Metz, O. Diekmann, The Dynamics of Physiologically Structured Populations, Volume 68 of Lecture Notes in Biomathematics, Springer, New York, 1986.
69. P. Michel, S. Mischler, and B. Perthame General entropy equations for structured population models and scattering Comptes Rendus De L'Academie Des Sciences Serie I Mathématique 338 2004 697 702 (Pubitemid 38491758)
70. P. Michel, S. Mischler, and B. Perthame The entropy structure of models of structured population dynamics. General Relative Entropy inequality: an illustration on growth models Journal de Mathematiques Pures et Appliquees 84 2005 1235 1260 (Pubitemid 41213693)
71. D. Morgan The Cell Cycle: Principles of Control 2006 Primers in Biology series Oxford University Press
72. M.C. Mormont, J. Waterhouse, P. Bleuzen, S. Giacchetti, A. Ami, A. Bogdan, J. Lellouch, J.L. Misset, Y. Touitou, and F. Lévi Marked 24-h rest-activity rhythms are associated with better quality of life, better response and longer survival in patients with metastatic colorectal cancer and good performance status Clinical Cancer Research 2000 3038 3045 (Pubitemid 30637726)
73. J. Nocedal, and S. Wright Numerical Optimization 1999 Springer New York
74. M.L. Overton Large-scale optimization of eigenvalues SIAM Journal on Optimization 2 1991 88 120
75. M.L. Overton, and R.S. Womersley On minimizing the spectral radius of a nonsymmetric matrix function: optimality conditions and duality theory SIAM Journal on Matrix Analysis and Applications 9 1988 473 498
76. B. Perthame, Transport Equations in Biology, Frontiers in Mathematics series, Birkhäuser, Boston, 2007.
77. G.J. Peters, J. Lankelma, R.M. Kok, P. Noordhuis, C.J. van Groeningen, and C.L. van der Wilt Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma Cancer Chemotherapy and Pharmacology 31 1993 269 276 (Pubitemid 23029150)
78. S.M. Reppert, and D.R. Weaver Coordination of circadian timing in mammals Nature 418 2002 935 941 (Pubitemid 34976023)
79. T. Rich, P.F. Innominato, J. Boerner, M.C. Mormont, S. Iacobelli, B. Baron, C. Jasmin, and F. Lévi Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity pattern in patients with metastatic colorectal cancer Clinical Cancer Research 11 2005 1757 1764 (Pubitemid 40471837)
80. A. Sakaue-Sawano, H. Kurokawa, T. Morimura, A. Hanyu, H. Hama, H. Osawa, S. Kashiwagi, K. Fukami, T. Miyata, H. Miyoshi, T. Imamura, M. Ogawa, H. Masai, and A. Miyawaki Visualizing spatiotemporal dynamics of multicellular cell-cycle progression Cell 32 2008 487 498 (Pubitemid 351191996)
81. A. Sakaue-Sawano, K. Ohtawa, H. Hama, M. Kawano, M. Ogawa, and A. Miyawaki Tracing the silhouette of individual cells in S/G2/M phases with fluorescence Chemistry & Biology 15 2008 1243 1248 (Pubitemid 352841470)
82. U. Schibler, and P. Sassone-Corsi A web of circadian pacemakers Cell 111 2002 919 922 (Pubitemid 36044683)
83. V. Shahreazaei, and P.G. Swain Analytical distributions for stochastic gene expression Proceedings of the National Academy of Sciences of the United States of America 105 2008 17256 17261
84. E. Sherer, E. Tocce, R.E. Hannemann, A.E. Rundell, and D. Ramkrishna Identification of age-structured models: cell cycle phase transitions Biotechnology and Bioengineering 99 2008 960 974 (Pubitemid 351316638)
85. R. Smaaland, O.D. Laerum, K. Lote, O. Sletvold, R.B. Sothern, and R. Bjerknes DNA synthesis in human bone marrow is circadian stage dependent Blood 77 1991 2603 2611
86. R.G. Staudte Planning blocked mitosis experiments for efficient estimation of population-doubling time and cell-cycle time Biometrics 38 1982 777 785
87. K. Vermeulen, D.R. Van Bockstaele, and Z.N. Berneman The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer Cell Proliferation 36 2003 131 149 (Pubitemid 36808270)
88. M.H. Vitaterna, D.P. King, A.M. Chang, J.M. Kornhauser, P.L. Lowrey, J.D. McDonald, W.F. Dove, L.H. Pinto, F.W. Turek, and J.S. Takahashi Mutagenesis and mapping of a mouse gene, clock, essential for circadian behavior Science 264 1994 719 725 (Pubitemid 24185884)
89. B. Vogelstein, D. Lane, and A.J. Levine Surfing the p53 network Nature 408 2000 307 310
90. T. Zhang, P. Brazhnik, and J.J. Tyson Exploring mechanisms of the DNA-damage response: p53 pulses and their possible relevance to apoptosis Cell Cycle 2007 85 94 (Pubitemid 46178023)
91. X. Zhang, F. Liu, W. Wang, Two-phase dynamics of p53 in the DNA damage response, Proceedings of the National Academy of Sciences of the United States of America, 2011 (Epub ahead of print).
92. L. Zitvogel, L. Apetoh, F. Ghiringhelli, and G. Kroemer Immunological aspects of cancer chemotherapy Nature Reviews: Immunology 8 2008 59 73